Baird analyst Catherine Schulte maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and lowers the price target from $56 to $33.
‘Fearless’ Taylor Swift Passes Madonna On Richest Self-Made Women List — Here’s Who Else The ‘All Too Well’ Singer Ranks Ahead Of
Taylor Swift is having a huge 2023 year. The singer has a massive tour of sold-out shows and singles charting in the Billboard Hot 100. Swift is also moving up the list of wealthiest self-made women andjust passed one of the top female musicians of all time.
